Company: PRME
Filing Date: 2025-07-31
Form Type: 8-K
Source: 0001628280-25-037076
Chunk: 2

Company: Prime Medicine, Inc.
Filing Date: 2025-07-31
Form: 8-K
Item: Item 1.01
Chunk 2
---
 31, 2024, Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, and any of its subsequent filings with the SEC. In addition, any forward-looking statements represent the Company’s views only as of today and should not be relied upon as representing its views as of any subsequent date. The Company explicitly disclaims any obligation to update any forward-looking statements, except as required by law. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements.

Item 9.01 - Financial Statements and Exhibits